I
Immatics NV D
D
IMTX
6.10000
USD
-0.04
(-0.65%)
مغلق
حجم التداول
21,649
الربح لكل سهم
0
العائد الربحي
-
P/E
-31
حجم السوق
741,456,031
الأخبار المقالات
العنوان: Immatics NV
القطاع: Healthcare
الصناعة: Biotechnology
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.